“While prevailing treatment approaches only address the symptoms associated with narcolepsy type 1, we believe orexin agonists offer a disruptive approach, with the capacity to address the underlying pathology of the disorder."
The company has suspended dosing of patients and has decided to stop both Phase 2 studies early.
An American Academy of Dental Sleep Medicine task force provides a consensus-based definition, as well as supported methods for measurement.
The trial will evaluate the treatment benefits and safety of applying mild external vacuum over the upper airway with the aerSleep II device in subjects with moderate and severe OSA who are unable to use standard therapy with CPAP.
As a result of the pandemic, many Americans are experiencing insomnia at elevated rates — especially parents, whose busy schedules were already prone to bouts of sleepless nights.
The Patients at the Heart program was created in 2019, and awards funds to not-for-profit organizations working to support and address the challenges of people living with sleep disorders and rare diseases who EDS.
In a transcriptome-wide study, researchers pinpoint PPP3R1 and other novel genetic risk factors of interest in RLS.
A new University of Colorado Boulder study suggests prebiotics, which serve as food for beneficial gut bacteria, could play an important role in helping people bounce back from jet lag.
"We can see complications in the small blood vessels of the brain in patients with RBD, although these patients don't otherwise have any symptoms."